---
document_datetime: 2023-09-21 17:28:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/caprelsa-epar-all-authorised-presentations_en.pdf
document_name: caprelsa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8064725
conversion_datetime: 2025-12-21 20:50:44.55294
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented)   | Strength   | Pharmaceutical     | Route of       | Packaging              | Package size   |
|-----------------|--------------|------------|--------------------|----------------|------------------------|----------------|
|                 | name         |            | Form               | Administration |                        |                |
| EU/1/11/749/001 | Caprelsa     | 100 mg     | Film-coated tablet | Oral use       | blister (PVC/PVDC/Alu) | 30 tablets     |
| EU/1/11/749/002 | Caprelsa     | 300 mg     | Film-coated tablet | Oral use       | blister (PVC/PVDC/Alu) | 30 tablets     |